2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$3.75+$0.05 (+1.35%)
Price as of Jul 14, 2026 4:08 AM EDT- $818.6MMarket Cap
- 54.81%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$3.75+$0.05 (+1.35%)
CTMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.70 | ||
Change | -$0.06 (-1.60%) | ||
Open | $3.69 | ||
High | $3.79 | ||
Low | $3.63 | ||
Previous Close | $3.76 | ||
Volume | 3,314,274 | ||
30-Day Average Volume | 6,081,362 | ||
1-Week Change | -2.89% | ||
1-Month Change | 22.92% | ||
1-Year Change | 54.81% | ||
3-Year Change | 104.42% | ||
5-Year Change | -37.92% | ||
Fundamentals | |||
Shares Outstanding | 217.7M | ||
Total Assets | $359.4M | ||
Market Cap | $818.6M | ||
Enterprise Value | $789.7M | ||
Period: QTR TTM FY | |||
Revenue | $10.3M | ||
Net Income | -$18.2M | ||
Free Cash Flow | -$25.5M | ||
EBIT | -$18.2M | ||
EBITDA | -$18.2M | ||
Net Working Capital | $319.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -44 | ||
Enterprise Value/Revenue | 77 | ||
P/B | 3 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue